Transgenic Research

, Volume 12, Issue 2, pp 203–212

Improved in Planta Expression of the Human Islet Autoantigen Glutamic Acid Decarboxylase (GAD65)

Authors

  • Linda Avesani
    • Dipartimento Scientifico e TecnologicoUniversità degli Studi di Verona
  • Alberto Falorni
    • Dipartimento di Medicina Interna, Sezione di Medicina Interna e Scienze Endocrine e MetabolicheUniversità degli Studi di Perugia
  • Giovanni Battista Tornielli
    • Dipartimento Scientifico e TecnologicoUniversità degli Studi di Verona
  • Carla Marusic
    • ENEA, Centro Ricerche Trisaia UTS BIOTEC
  • Andrea Porceddu
    • Istituto di Ricerche sul Miglioramento Genetico Piante Foraggere del CNR
  • Annalisa Polverari
    • Dipartimento Scientifico e TecnologicoUniversità degli Studi di Verona
  • Claudia Faleri
    • Dipartimento di Scienze AmbientaliUniversità di Siena
  • Filippo Calcinaro
    • Dipartimento di Medicina Interna, Sezione di Medicina Interna e Scienze Endocrine e MetabolicheUniversità degli Studi di Perugia
  • Mario Pezzotti
    • Dipartimento Scientifico e TecnologicoUniversità degli Studi di Verona
Article

DOI: 10.1023/A:1022947726557

Cite this article as:
Avesani, L., Falorni, A., Tornielli, G.B. et al. Transgenic Res (2003) 12: 203. doi:10.1023/A:1022947726557

Abstract

The smaller isoform of the enzyme glutamic acid decarboxylase (GAD65) is a major islet autoantigen in autoimmune type 1 diabetes mellitus (T1DM). Transgenic plants expressing human GAD65 (hGAD65) are a potential means of direct oral administration of the islet autoantigen in order to induce tolerance and prevent clinical onset of disease. We have previously reported the successful generation of transgenic tobacco and carrot that express immunoreactive, full-length hGAD65. In the present study, we tested the hypothesis that the expression levels of recombinant hGAD65 in transgenic plants can be increased by targeting the enzyme to the plant cell cytosol and by mediating expression through the potato virus X (PVX) vector. By substituting the NH2-terminal region of hGAD65 with a homologous region of rat GAD67, a chimeric GAD671-87/GAD6588-585 molecule was expressed in transgenic tobacco plants. Immunolocalization analysis showed that immunoreactive GAD67/65 was found in the plant cell cytosol. By using a radio-immuno assay with human serum from a GAD65 autoantibody-positive T1DM patient, the highest expression level of the recombinant GAD67/65 protein was estimated to be 0.19% of the total soluble protein, compared to only 0.04% of wild-type hGAD65. Transient expression of wild-type, full-length hGAD65 in N. benthamiana mediated by PVX infection was associated with expression levels of immunoreactive protein as high as 2.2% of total soluble protein. This substantial improvement of the expression of hGAD65 in plants paves the way for immunoprevention studies of oral administration of GAD65-containing transgenic plant material in animal models of spontaneous autoimmune diabetes.

autoimmunitydiabetes mellitusGAD65oral tolerancetransgenic plantstransient expression

Copyright information

© Kluwer Academic Publishers 2003